Spruce Biosciences Inc (SPRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 98,801 | 97,482 | 73,926 | 24,487 | 21,649 |
| Marketable Securities | 9,231 | 23,041 | 44,659 | 54,590 | 68,751 |
| Receivables | N/A | N/A | 15,000 | N/A | N/A |
| Other current assets | 419 | 206 | 253 | 1,211 | 0 |
| TOTAL | $111,138 | $124,129 | $137,236 | $83,608 | $93,186 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 1,847 | 1,833 | 1,878 | 2,040 | 2,112 |
| TOTAL | $1,847 | $1,833 | $1,878 | $2,040 | $2,112 |
| Total Assets | $112,985 | $125,962 | $139,114 | $85,648 | $95,298 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,622 | 1,622 | 1,622 | 1,622 | 1,216 |
| Accounts payable and accrued liabilities | 3,152 | 945 | 3,448 | 1,426 | 2,181 |
| Accrued Expenses | 11,616 | 12,107 | 8,720 | 9,399 | 8,604 |
| TOTAL | $24,188 | $22,734 | $22,995 | $12,447 | $12,001 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,113 | 2,507 | 2,901 | 3,293 | 3,685 |
| Deferred Revenues | 7,798 | 8,060 | 9,205 | N/A | N/A |
| Other Non-Current Liabilities | 1,303 | 1,349 | 1,390 | 1,422 | 1,137 |
| TOTAL | $3,416 | $6,667 | $8,122 | $4,715 | $4,822 |
| Total Liabilities | $27,604 | $29,401 | $31,117 | $17,162 | $16,823 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 541 | 541 | 529 | 529 | 313 |
| Common Shares | 4 | 4 | 4 | 3 | 3 |
| Retained earnings | -187,282 | -174,928 | -162,104 | -149,313 | -138,169 |
| Other shareholders' equity | -3 | -55 | -188 | -558 | -873 |
| TOTAL | $85,381 | $96,561 | $107,997 | $68,486 | $78,475 |
| Total Liabilities And Equity | $112,985 | $125,962 | $139,114 | $85,648 | $95,298 |